Globus Medical Inc (Globus) is a provider of musculoskeletal implants. The company focuses on developing products for spine surgery. It offers solutions for various spine procedures such as anterior cervical, anterior lumbar, lateral, motion preservation, posterior cervical, posterior lumbar, sacroiliac joint fixation, spinous process fixation, vertebral augmentation and vertebral body replacement.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

The R&D of Globus focuses on the development of innovative products and the improvement of existing products with therapy areas related to musculoskeletal disorders and lifestyle. In FY2023, Globus spent US$73.01 million on its R&D activities, amounting to 7.1% of the company's total revenue. The company's enabling technologies comprise of imaging, navigation and robotics (INR) solutions that are used in surgery. Its INR solutions include ExcelsiusGPS platform, a robotic guidance and navigation system for clinical applications. The company also offers Surgimap, a surgical planning software platform. As of FY2023, in the US, the company had 2,583 issued patents (2,547 utility patents and 36 design patents); 867 pending patent applications (866 utility patents and one design patents); and 1,744 issued foreign patents and 502 pending foreign patent applications in other countries. Its trademark portfolio includes 732 registered trademarks and 196 trademarks pending registration.